DealsTPG invests in clinical trial site platform K2 Medical ResearchK2 was founded by CEO Sean Stanton and Chief Medical Officer Brandon Lenox.ByIris Dorbian17 June 2024•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsNorth AmericaUSHealthcareBriefs